| MRT | magnetic resonance tomography; maximum relaxation time; median range score; median reaction time; me... |
|---|---|
| PST | pancreatic suppression test; paroxysmal supraventricular tachycardia; penicillin, streptomycin, and ... |
| RT | radiologic technologist; radiotelemetry; radiotherapy; radium therapy; rapid tranquilization; reacti... |
| TE | echo-time; expiratory time; tennis elbow; test ear; tetanus; tetracycline; threshold energy; thrombo... |
| TR | recovery time; rectal temperature; repetition time; residual tuberculin; terminal repeat; tetrazoliu... |
| time-varied gain | In ultrasonography, an increase in receiver gain with time to compensate for loss in echo amplitude with depth, usually due to attenuation. Synonym: attenuation compensation, depth compensation, time compensation gain, time-compensated gain, time-varied gain control, time-varied gain. (05 Mar 2000) |
|---|---|
| time-varied gain control | In ultrasonography, an increase in receiver gain with time to compensate for loss in echo amplitude with depth, usually due to attenuation. Synonym: attenuation compensation, depth compensation, time compensation gain, time-compensated gain, time-varied gain control, time-varied gain. (05 Mar 2000) |
| tissue thromboplastin inhibition time | A test used to identify lupus anticoagulant; the thromboplastin source used in the prothrombin test is diluted to increase sensitivity to inhibitors. (05 Mar 2000) |
| energy confinement time | <radiobiology> Characteristic time in which 1/e (or sometimes 1/2) of a system's energy is lost to its surroundings. In a plasma device, the energy loss time (or the energy confinement time) is one of three critical parameters determining whether enough fusion will occur to sustain a reaction. See: Lawson criterion. (09 Oct 1997) |
| energy replacement time | <radiobiology> Time required for a plasma to lose (via radiation or other loss mechanisms) an amount of energy equal to its average kinetic energy. (09 Oct 1997) |
| euglobulin clot lysis time | A measure of the ability of plasminogen activators and plasmin to lyse a clot; normally, clot lysis is determined by the balance of factors which activate fibrinolysis (plasminogen activators and plasmin) and those which inhibit lysis; in certain conditions (e.g., carcinoma or hepatic insufficiency) activating factors predominate and can be measured by noting the time it takes the euglobulin fraction of plasma (excluding inhibitors of fibrinolysis) to clot. (05 Mar 2000) |
| fading time | The time required for a constant stimulus applied to a fixed area of the peripheral visual field to stop. (05 Mar 2000) |
| zero time-binding DNA | DNA that has become the duplex form at the start of a reassociation process. Acronym: DNA (05 Mar 2000) |
| utilization time | The minimum duration of a stimulus of rheobasic strength that is just sufficient to produce excitation. Synonym: temps utile. (05 Mar 2000) |
| forced expiratory time | The time taken to expire a given volume or a given fraction of vital capacity during measurement of forced vital capacity; subscripts specify the exact parameters measured. (05 Mar 2000) |
| left ventricular ejection time | The time measured clinically from onset to incisural notch of the carotid or other pulse; properly the time of ejection of blood from the left ventricle beginning with aortic valve opening and ending with aortic valve closure. (05 Mar 2000) |
| accelerator factor | <chemical> Heat- and storage-labile plasma glycoprotein which accelerates the conversion of prothrombin to thrombin in blood coagulation. Factor v accomplishes this by forming a complex with factor xa, phospholipid, and calcium (prothrombinase complex). Deficiency of factor v leads to owren's disease. Chemical name: Blood-coagulation factor V (12 Dec 1998) |
| acetate replacement factor | <biochemistry> 1,2 dithiolane 3 valeric acid. Regarded as a coenzyme in the oxoglutarate dehydrogenase complex of the citric acid cycle. Involved generally in oxidative decarboxylations of _ keto acids. A growth factor for some organisms. (18 Nov 1997) |
| adrenal weight factor | A postulated substance of adenohypophysial origin responsible for maintenance of the weight of the adrenal cortex. (05 Mar 2000) |
| adrenocorticotropic releasing factor | Hormone produced by hypothalamus that causes pituitary to secrete adrenocorticotropic hormone. (05 Mar 2000) |